Octamer-binding transcription factor 4-positive circulating tumor cell predicts worse treatment response and survival in advanced cholangiocarcinoma patients who receive immune checkpoint inhibitors treatment

This study ...

Source: World Journal of Surgical Oncology - April 25, 2024 Category: Cancer & Oncology Authors: Fei Pei, Zhen Tao, Qi Lu, Tao Fang and Shasha Peng Tags: Research Source Type: research